| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412946A1 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 01/10/2002 | CA2412925A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | CA2412882A1 Peptide extended glycosylated polypeptides |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412847A1 Dual recombinant gene therapy compositions and methods of use |
| 01/10/2002 | CA2412845A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 01/10/2002 | CA2412775A1 Antibodies to human mcp-1 |
| 01/10/2002 | CA2412292A1 Base analogues |
| 01/10/2002 | CA2411794A1 Signal amplification with lollipop probes |
| 01/10/2002 | CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | CA2410953A1 Adenylyl and guanylyl cyclases |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2410551A1 Heterodimeric fusion proteins |
| 01/10/2002 | CA2408829A1 Regulated gene expression in yeast and methods of use |
| 01/10/2002 | CA2407910A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | CA2406643A1 Natural promoters for gene expression and metabolic monitoring in bacillus species |
| 01/09/2002 | EP1170383A2 Oligonucleotides and method for detection of small round structured virus (SRSV) RNA |
| 01/09/2002 | EP1170382A2 Method for diagnosing a bacterial infection in the crassostrea gigas oyster larvae |
| 01/09/2002 | EP1170381A2 Method for the non-specific amplification of nucleic acid |
| 01/09/2002 | EP1170380A2 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 01/09/2002 | EP1170376A1 Method for producing substances utilizing microorganisms |
| 01/09/2002 | EP1170374A1 Method for preperation of microprojectiles for efficient delivery of biologicals using a particle gun |
| 01/09/2002 | EP1170373A1 Peptide-mediated ocular cell transfection |
| 01/09/2002 | EP1170372A1 Regulatory sequences of the human MCP-1 gene |
| 01/09/2002 | EP1170371A1 Phosphohexuloisomerase and gene therefor |
| 01/09/2002 | EP1170370A2 Method for producing nucleotide by fermentation |
| 01/09/2002 | EP1170369A1 Extracellular protease from acremonium chrysogenum with cpc-acetyl hydrolase activity and its utilization in the synthesis of deacetylated derivatives of cephalosporin c and inactivation of the gene for increasing production of cephalosporin |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1170367A1 BVDV virus-like particles |
| 01/09/2002 | EP1170366A1 Secreted proteins obtained by using Yeast invertase gene as reporter system |
| 01/09/2002 | EP1170365A1 Member of the ion channel family of polypeptides; vanilrep4 |
| 01/09/2002 | EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility |
| 01/09/2002 | EP1170363A1 Virus envelope vector for gene transfer |
| 01/09/2002 | EP1170362A2 Cloning and expressing restriction endonucleases and modification methylases from caryophanon |
| 01/09/2002 | EP1170361A2 New mutant N-Acetylglutamate synthase and method for L-Arginine production |
| 01/09/2002 | EP1170358A1 L-arginine producing Escherichia coli and method of producing L-arginine |
| 01/09/2002 | EP1170300A1 Method for modification of recombinant polypeptides |
| 01/09/2002 | EP1170016A2 Urease-based vaccine against helicobacter infection |
| 01/09/2002 | EP1169481A1 Method of identifying toxic agents using differential gene expression |
| 01/09/2002 | EP1169480A1 Tissue-specific and pathogen-specific toxic agents and ribozymes |
| 01/09/2002 | EP1169479A2 Methods for detecting nucleic acids indicative of cancer |
| 01/09/2002 | EP1169478A2 Method for identifying organisms by means of comparative genetic analysis and primers and hybridisation probes for carrying out this method |
| 01/09/2002 | EP1169477A1 ISOLATION OF cDNA ENCODING FOR SECRETED OR MEMBRANAL PROTEINS |
| 01/09/2002 | EP1169476A1 Detection of melanoma |
| 01/09/2002 | EP1169472A2 Compound assay using nematodes |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169466A1 Synthesis of 1,2,3,4-tetrahydroxybenzenes and 1,2,3-trihydroxybenzenes using myo-inositol-1-phosphate synthase and myo-inositol 2-dehydrogenase |
| 01/09/2002 | EP1169465A1 Two-step immunization procedure against chlamydia infection |
| 01/09/2002 | EP1169464A1 Recombinant and mutant adenoviruses derived of bovine adenovirus type 1 |
| 01/09/2002 | EP1169463A1 Method for conveying bnyvv resistance to sugar beet plants |
| 01/09/2002 | EP1169462A2 Transgenic plants containing altered levels of sterol compounds and tocopherols |
| 01/09/2002 | EP1169461A2 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use |
| 01/09/2002 | EP1169460A2 Preparation of biologically active molecules |
| 01/09/2002 | EP1169459A1 Dsp-9 dual-specificity map kinase phosphatase |
| 01/09/2002 | EP1169458A2 Method for selecting recombinase variants with altered specificity |
| 01/09/2002 | EP1169457A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/09/2002 | EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
| 01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 01/09/2002 | EP1169454A1 Protein sweetener |
| 01/09/2002 | EP1169453A1 Inhibition of viral infection using monovalent antigen-binding proteins |
| 01/09/2002 | EP1169452A1 Viral variants |
| 01/09/2002 | EP1169451A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 01/09/2002 | EP1169450A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/09/2002 | EP1169449A2 Clasp-2 transmembrane proteins |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169447A1 Genes and expression products from hematopoietic cells |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169443A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21 |
| 01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2002 | EP1169441A2 Treatment of cardiac power failure using s100 proteins |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169439A1 Combinatorial method for producing nucleic acids |
| 01/09/2002 | EP1169438A1 Pcr-based cloning method |
| 01/09/2002 | EP1169437A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology |
| 01/09/2002 | EP1169434A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/09/2002 | EP1169433A1 Human hac3 |
| 01/09/2002 | EP1169353A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 01/09/2002 | EP1169352A1 Erythropoietin receptor antibodies |
| 01/09/2002 | EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169344A1 47 human secreted proteins |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169341A1 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 01/09/2002 | EP1169340A1 Lantibiotic |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169330A2 Information-carrying and information-processing polymers |
| 01/09/2002 | EP1169282A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 01/09/2002 | EP1169122A2 Spatially directed interaction on a solid surface |
| 01/09/2002 | EP1169063A2 Treatment of intracellular infection |
| 01/09/2002 | EP1169058A1 Insulin-like growth factor binding protein-4 protease |
| 01/09/2002 | EP1169054A2 Products and methods for treating ptp lar related diseases |